Horizon Pharma Inc. (HZNP) posted Friday a narrower fourth-quarter loss of $76.7 million compared to last year's loss of $13.6 million. Adjusted loss was $19.0 million in the recent quarter and $11.7 million a year ago.
Per-share loss, however, narrowed to $3.92 per share from a loss of $9.09 reflecting a sharply higher share count. Adjusted per-share loss was $0.97 per share compared to a loss of $7.85.
Net revenues went up to $3.5 million from $0.03 million in the prior-year thanks to higher European sales of Lodotra and the recognition of $1.2 million of deferred revenues. Three analysts polled by Thomson Reuters estimated revenues of $2.60 million.
by RTT Staff Writer
For comments and feedback: email@example.com